GeoVax Labs Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | GeoVax Labs Inc.

GeoVax Labs Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

2,284.90

2,733.60

2,689.30

3,271.70

2,170.20

2,560.10

Depreciation, Depletion & Amortization

78.90

69.00

28.90

28.80

28.00

19.80

Other Funds

402.10

479.10

67.90

967.70

57.20

469.70

Funds from Operations

1,804.00

2,185.40

2,592.40

2,275.30

2,084.90

2,070.60

Changes in Working Capital

109.40

64.70

112.80

329.10

396.40

527.50

Net Operating Cash Flow

1,694.60

2,250.10

2,705.30

1,946.10

1,688.50

1,543

Capital Expenditures

86.60

35.50

15.90

4.40

Net Investing Cash Flow

86.60

35.50

15.90

4.40

Net Financing Cash Flow

3,259.10

873.40

2,679.80

1,339.80

1,551.50

Net Change in Cash

1,477.90

1,412.20

41.30

606.30

141.30

Free Cash Flow

1,781.20

2,285.60

2,721.10

1,946.10

1,692.80

Change in Capital Stock

3,259.10

873.40

2,679.80

1,339.80

1,551.50

About GeoVax Labs

View Profile

Address	1900 Lake Park Drive Smyrna Georgia 30080 United States
Employees	-
Website	http://www.geovax.com
Updated	07/08/2019
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G.